Russian Federation vs Russian Federation: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Russian Federation
0.1%
in 2024
Russian Federation
0.1%
in 2024
Russian Federation rank
134th
Russian Federation rank
134th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Russian Federation
- Russian Federation
How they compare
Russian Federation currently reports 0.1% against 0.1% in Russian Federation, a difference of 0.0%.
Across all 10 years both countries report, Russian Federation has been ahead every year.
Russian Federation ranks 134th and Russian Federation ranks 134th of 246 countries.
Head to head by decade
| Decade | Russian Federation | Russian Federation | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.0% | — |
| 2020s | 0.1% | 0.1% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Russian Federation or Russian Federation?
- Russian Federation, at 0.1% against 0.1% in Russian Federation as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Russian Federation and Russian Federation?
- 0.0%, with Russian Federation ahead.
- How many years of comparable data are there for Russian Federation and Russian Federation?
- 10 years are reported by both, from 2015 to 2024.
- How do Russian Federation and Russian Federation rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Russian Federation ranks 134th and Russian Federation ranks 134th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.